New cholesterol drug lowers heart attack, death risk in study

Praluent, a new cholesterol drug, lowered heart attack and death risk, according to a study sponsored by Sanofi and Regeneron Pharmaceuticals.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news